Cambridge, MA, United States of America

CharChang Lai


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: CharChang Lai: Innovator in Recombinant Protein Production

Introduction

CharChang Lai is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein production. With a total of 2 patents, his work has implications for various applications in medicine and virology.

Latest Patents

CharChang Lai's latest patents focus on an ICP0-mediated enhanced expression system. This system encompasses methods and compositions for increasing the production of recombinant proteins by introducing ICP0 to cells capable of producing a recombinant protein. In one method, the recombinant protein is essential for the replication of a replication-defective virus, wherein the recombinant protein is provided to the replication-defective virus in trans. This innovative approach has the potential to enhance the efficiency of protein production in various biotechnological applications.

Career Highlights

Throughout his career, CharChang Lai has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Sanofi Pasteur Inc. and Sanofi Pasteur Biologics, LLC. His experience in these organizations has allowed him to contribute to significant advancements in vaccine development and biopharmaceuticals.

Collaborations

CharChang Lai has collaborated with various professionals in his field, including Simon Delagrave. These collaborations have fostered innovation and the sharing of ideas, further enhancing the impact of his work.

Conclusion

CharChang Lai's contributions to recombinant protein production through his innovative patents and career in biotechnology highlight his role as a significant inventor in the field. His work continues to influence advancements in medical and biotechnological research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…